Wolwo Pharma: The first subject has been enrolled in the Phase I clinical trial of the house dust mite membrane agent
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, Wolwo Pharma announced that the "house dust mite film agent" developed by the company has completed the enrollment of the first subject in the "Clinical Study on the Safety and Tolerability of Sublingual Administration of 'House Dust Mite Film Agent' in Chinese Adults with Dust Mite Allergic Rhinitis" at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, officially entering this clinical trial
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments